遗传证据显示,类胆作为omega-3和多发性骨髓瘤风险之间的因果关系的调解者
Jian Li1,2, Youxuan Li3, Jun Wang3
1The First College of Clinical Medicine, Guizhou University of Traditional Chinese Medicine, No. 71, Baoshan North Road, Yunyan District, Guiyang, 550001, Guizhou Province, China.
Scientific reports
|August 8, 2025
概括
欧米茄-3脂肪酸可以降低多发性骨髓瘤 (MM) 的风险. 这项孟德尔随机化研究发现了一种因果关系,可能由酸丁胆介导,这表明了MM的新预防策略.
科学领域:
- 营养流行病学 营养流行病学
- 遗传流行病学遗传流行病学
- 癌症研究 癌症研究
背景情况:
- 观察性研究表明,omega-3脂肪酸可能会降低癌症风险.
- 欧米茄-3摄入量与多发性骨髓瘤 (MM) 发病率之间的特定关联需要澄清.
研究的目的:
- 使用孟德尔随机化 (MR) 调查omega-3脂肪酸与MM风险之间的因果关系.
- 探索血脂在欧米茄-3和MM协会中的潜在调解作用.
主要方法:
- 使用大型全基因组关联研究 (GWAS) 数据进行了双样本和多变量门德尔随机化 (MR) 分析.
- 对MR的元分析结果来自四个独立的omega-3 GWAS数据集.
- 两步式MRI被用于识别潜在的脂质介质.
主要成果:
- 对MR结果的元分析表明,基因预测较高的欧米茄-3水平与MM风险降低有关 (OR=0.80,P<0.001).
- 多变量MR在调整肥胖和2型糖尿病后证实了这种反向关联.
- 类胆 (18:2_20:4) 被确定为omega-3-MM途径中的潜在调解物.
结论:
- 欧米茄-3脂肪酸似乎因果性地降低了患多发性骨髓瘤的风险.
- 酸胆 (18:2_20:4) 的水平增加可能会调解欧米茄-3对MM的保护作用.
- 这些发现为MM预防和治疗策略提供了潜在的新途径.
相关概念视频
Synthesis of Phosphatidylcholine in the ER Membrane
3.3K
The ER synthesizes lipids for building cell membranes and performing cellular functions such as energy storage and signaling. The lipid synthesis machinery embedded in the ER membrane primarily collects all reactants from the cytosol. Following synthesis, the secretory pathway and the ER contact sites distribute these lipids to other cellular organelles. Additionally, the energy-rich triacylglycerides are transported from the ER via lipid droplets.
The major components of all eukaryotic cell...
The major components of all eukaryotic cell...
3.3K
Cholesterol: Significance and Regulation
686
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
686
Atherosclerosis III: Management
35
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
35


